Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were diagnosed with Hodgkin lymphoma between the ages of 10 and 25 years old.
- People who are older than 10 and younger than 25 years old at the time of joining the trial.
- People who finished treatment for Hodgkin lymphoma (either chemotherapy or radiation therapy, whichever came last) within the past 24 months, and who have recovered from any side effects of that treatment.
- People who have been cleared by a doctor to take part in physical activity.
- People who are able to understand how to use a web-based platform on a provided iPad and heart rate monitor.
Who may not be able to join:
- People whose Hodgkin lymphoma has come back (relapsed).
- People who have been diagnosed with acute heart failure.
- People who are currently doing high-intensity interval training (HIIT) or more than 420 minutes per week of moderate to vigorous physical activity.
- People who are currently pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amy Berkman, MD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participation rate (percent of eligible participants approached who enroll); Completion rate (percentage of scheduled HIIT sessions attended and percentage of post-intervention testing sessions completed)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.